Dr. Jarob Saker has a diverse background in the field of medical and clinical research, with experience in managing clinical studies, product development, and scientific research. Their current roles involve supervising PhD programs and leading interdisciplinary project groups, as well as building relationships with key opinion leaders in the industry. They have a strong foundation in biology and have worked on a variety of projects related to radiolabeled EGFR inhibitors.